Alps Advisors Inc Co Diagnostics, Inc. Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.03 - $9.61 $191,150 - $365,199	-38,002 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$8.12 - $10.37 $3,986 - $5,091	491 Added 1.31%	38,002 $339,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $92,086 - $140,099	12,311 Added 48.85%	37,511 $365,000
Q1 2021 May 07, 2021	BUY	$8.52 - $19.21 $214,704 - $484,092	25,200 New	25,200 $240,000

4.29M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $25M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.